ANTIDEPRESSANTS AND BRUXISM: POSSIBLE ASSOCIATIONS AND CLINICAL IMPLICATIONS
DOI:
https://doi.org/10.63330/sasciencesv6n2-267Keywords:
Antidepressive agents, Bruxism, Drug-related side effects and adverse reactions, Selective serotonin reuptake inhibitorsAbstract
Bruxism is a repetitive activity of the masticatory muscles, characterized by clenching or grinding of the teeth and/or by mandibular thrusting, that may occur during sleep or wakefulness and is related to multiple factors, including medication use, with possible clinical consequences. This study aimed to analyze the available evidence on the association between antidepressant use and sleep and awake bruxism, considering the possible mechanisms involved and the clinical implications. An integrative literature review was carried out, with searches in PubMed, LILACS (through the Virtual Health Library) and SciELO from January 2015 to October 2026, plus a complementary manual search, resulting in 11 studies included in the main synthesis. The studies pointed to signs of association between antidepressants, mainly selective serotonin reuptake inhibitors and serotonin-norepinephrine reuptake inhibitors, and bruxism. Among the drugs, paroxetine, fluoxetine and duloxetine showed increased sleep bruxism in short-term follow-up studies; paroxetine, venlafaxine and duloxetine were the most associated in a cross-sectional observational study based on self-report, which does not allow a causal relationship between the drug and bruxism to be established; and the signals for the other antidepressants come from pharmacovigilance reports. The mechanisms discussed involve the serotonergic, dopaminergic and noradrenergic systems, with manifestations described after treatment initiation or dose increase. The heterogeneity of assessment methods, the predominance of observational studies and the influence of psychological and sleep-related factors limit causal inference. It is concluded that antidepressants may be associated with the onset or intensification of bruxism manifestations in some individuals, that longitudinal studies with standardized assessment methods are needed, and that medication history and interdisciplinary work should be part of the dental assessment.
Downloads
References
CASPARY ROITHMANN, C. et al. Relationship between bruxism and depression: systematic literature review and meta-analysis. International Journal of Prosthodontics, 2025. DOI: 10.11607/ijp.9385.
CLIATT, H.; WILLIAMS, A.; KOCH, C. Management of antidepressant-induced bruxism. Mental Health Clinician, v. 15, n. 3, p. 147-149, 2025. DOI: 10.9740/mhc.2025.06.147.
DE BAAT, C. et al. Medications and addictive substances potentially inducing or attenuating sleep bruxism and/or awake bruxism. Journal of Oral Rehabilitation, v. 48, n. 3, p. 343-354, 2021. DOI: 10.1111/joor.13061.
GARRETT, A. R.; HAWLEY, J. S. SSRI-associated bruxism: a systematic review of published case reports. Neurology: Clinical Practice, v. 8, n. 2, p. 135-141, 2018. DOI: 10.1212/CPJ.0000000000000433.
GEORGE, S.; JOY, R.; ROY, A. Drug-induced bruxism: a comprehensive literature review. Journal of Advanced Oral Research, v. 12, n. 2, p. 187-192, 2021. DOI: 10.1177/2320206821992534.
GOLDSTEIN, G.; DESANTIS, L.; GOODACRE, C. Bruxism: best evidence consensus statement. Journal of Prosthodontics, v. 30, supl. 1, p. 91-101, 2021. DOI: 10.1111/jopr.13308.
GOULART, P. R. et al. Anxiety, depression, and anger in bruxism: a cross-sectional study among adult attendees of a preventive center. Psychiatry Research, v. 299, 113844, 2021. DOI: 10.1016/j.psychres.2021.113844.
GÜLDIKEN, İ. et al. Investigation of the effect of the onset of bruxism as a result of early antidepressant use. Psychiatria Danubina, v. 36, n. 2, p. 225-231, 2024. DOI: 10.24869/psyd.2024.217.
HILGENBERG-SYDNEY, P. B. et al. Bruxism, lifestyle, anxiety, and sleep impairment in dental students. Sleep Science, v. 17, n. 4, p. e422-e428, 2024. DOI: 10.1055/s-0044-1782179.
LEONAN-SILVA, B. et al. Assessment of self-reported and clinically reported bruxism in studies on selective serotonin reuptake inhibitors and serotonin-norepinephrine reuptake inhibitors use: a critical appraisal aligned with the Standardized Tool for the Assessment of Bruxism principles. Journal of the American Dental Association, 2026. DOI: 10.1016/j.adaj.2026.04.016.
MANFREDINI, D. et al. Standardised tool for the assessment of bruxism. Journal of Oral Rehabilitation, v. 51, n. 1, p. 29-58, 2024.
MASSAHUD, M. L. B. et al. Association between sleep bruxism, use of antidepressants, and obstructive sleep apnea syndrome: a cross-sectional study. Journal of Oral Rehabilitation, v. 49, p. 505-513, 2022. DOI: 10.1111/joor.13312.
MINAKUCHI, H. et al. Managements of sleep bruxism in adult: a systematic review. Japanese Dental Science Review, v. 58, p. 124-136, 2022. DOI: 10.1016/j.jdsr.2022.02.004.
MONTASTRUC, J. L. Drugs and bruxism: a study in the World Health Organization pharmacovigilance database. British Journal of Clinical Pharmacology, v. 89, n. 12, p. 3765-3768, 2023. DOI: 10.1111/bcp.15884.
PALA AVAN, A. et al. Bruxism and sleep disorders in patients diagnosed with depressive disorder and anxiety disorder using antidepressants. Journal of Oral Rehabilitation, v. 52, n. 1, p. 57-63, 2025. DOI: 10.1111/joor.13875.
RAJAN, R.; SUN, Y. M. Reevaluating antidepressant selection in patients with bruxism and TMD. Primary Care Companion for CNS Disorders, v. 19, n. 3, 2017. DOI: 10.1097/PRA.0000000000000227.
SANTOS, I. M. et al. Prevalence of bruxism in users of selective serotonin reuptake inhibitors and serotonin-norepinephrine reuptake inhibitors: a retrospective cross-sectional study. Journal of Stomatology, Oral and Maxillofacial Surgery, v. 127, n. 3, 102710, 2026. DOI: 10.1016/j.jormas.2026.102710.
SOUZA, M. T.; SILVA, M. D.; CARVALHO, R. Revisão integrativa: o que é e como fazer. Einstein, São Paulo, v. 8, n. 1, p. 102-106, 2010. DOI: 10.1590/S1679-45082010RW1134.
VERHOEFF, M. C. et al. Updating the bruxism definitions: report of an international consensus meeting. Journal of Oral Rehabilitation, v. 52, n. 9, p. 1335-1342, 2025. DOI: 10.1111/joor.13985.
WALLEM, A.; FELIPE-SPADA, N.; TOMÀS-ALIBERAS, J. Influence of selective serotonin reuptake inhibitors (SSRIs) in the development of bruxism. CRANIO, v. 43, n. 2, p. 236-242, 2025. DOI: 10.1080/08869634.2022.2120277.
Downloads
Published
How to Cite
Issue
Section
License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Autores concordam com os seguintes termos:
a) Os autores mantêm os direitos autorais e concedem à revista o direito de primeira publicação, com o trabalho simultaneamente licenciado sob a LicençaAttribution-NonCommercial-ShareAlike 4.0 International, que permite o compartilhamento do trabalho com reconhecimento da autoria e publicação inicial na Revista SAS. A licença permite o uso, a distribuição e a reprodução irrestrita, em qualquer meio, desde que devidamente citada a fonte. Essa licença permite também que outros remixem, adaptem e criem a partir do seu trabalho para fins não comerciais, desde que atribuam a você o devido crédito e que licenciem as novas criações sob termos idênticos.
b) Não cabe aos autores compensação financeira a qualquer título, por artigos ou resenhas publicados na South American Sciences.
c) Os conceitos expressos nos artigos publicados na South American Sciences são de inteira responsabilidade de seus autores.
